Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2016 · 10-Q
Revenue$130.97M$130.97M+14.7% vs Q3 2015 Net Income$30.29M$30.29M+24.7% vs Q3 2015 EPS Diluted$0.81$0.81+24.6% vs Q3 2015 Gross Profit$89,989,000+13.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$37,137,000+20.7% Free Cash Flowderived$34,301,000+32.7% Margins · derivedGross margin68.7%−0.8 pt vs Q3 2015
Operating margin33.2%−1.3 pt vs Q3 2015
Net margin23.1%+1.9 pt vs Q3 2015
ended Mar 31, 2016 · filed May 10, 2016 · 40 d after period end